Traceable Iron Oxide Based Nanoparticles for Antigen/Adjuvant in vivo Delivery to Lymph Nodes

Ane Ruiz de Angulo


Ane Ruiz de Angulo was born in Donostia (Basque Country, Spain) in 1989. She obtained her Biotechnology Degree from the Universitat Autònoma de Barcelona. During her Masters Degree in Biomedicine at the Universitat de Barcelona (UB), she worked on characterization of new therapies for fighting chemoresistance in ovarian cancer. Afterwards, she spent three months undertaking work experience at the ‘Basic, Translational and Molecular Neurogenetics Research Unit’ (IGTP Institute, Barcelona). Ane started her PhD at CICbiomaGUNE in November 2012. Her project is focused on developing new delivery systems with immunological activity in order to enhance the immune response against cancer cells


Most of the currently available vaccines are based on the inactivation of the pathogen, which is not a valid strategy for fighting several chronic infections and, especially, cancer.[1,2] Here we present PEGylated iron oxide... [ view full abstract ]


  1. Ane Ruiz de Angulo (CIC biomaGUNE)
  2. Aintzane Zabaleta (CIC biomaGUNE)
  3. Zuriñe Baz (CIC biomaGUNE)
  4. Jordi Llop (CIC biomaGUNE)
  5. Juan Carlos Mareque Rivas (CIC biomaGUNE)

Topic Areas

Nanomedecine for cancer diagnosis & therapy , Nano-Imaging for diagnosis, therapy and delivery


OS2-103 » Nanomedecine for cancer diagnosis & therapy (16:00 - Thursday, 29th September, Tower 24 - Room 103)

Presentation Files

The presenter has not uploaded any presentation files.